Related references
Note: Only part of the references are listed.In vitro differentiation of mesenchymal stem cells into mesangial cells when co-cultured with injured mesangial cells
Chee-Yin Wong et al.
CELL BIOLOGY INTERNATIONAL (2014)
MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1
Feng He et al.
DIABETOLOGIA (2014)
B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells
Frank Secreto et al.
LEUKEMIA & LYMPHOMA (2014)
B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A
Hannes Bergmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression
Chuan-Yin Sun et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2013)
Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse
Yasuhiko Tomino
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy
Douglas D. McCarthy et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Intrarenal production of B-cell survival factors in human lupus nephritis
Matthias A. Neusser et al.
MODERN PATHOLOGY (2011)
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study
Gro O. Eilertsen et al.
RHEUMATOLOGY (2011)
Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas
Vassiliki Pelekanou et al.
ANALYTICAL CELLULAR PATHOLOGY (2011)
Mesangial pathology in glomerular disease: targets for therapeutic intervention
Yogesh M. Scindia et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Selective Blockade of BAFF for the Prevention and Treatment of Systemic Lupus Erythematosus Nephritis in NZM2410 Mice
Meera Ramanujam et al.
ARTHRITIS AND RHEUMATISM (2010)
Spontaneous animal model, ddY mouse, for studying the pathogenesis and treatment in patients with immunoglobulin A nephropathy
Yasuhiko Tomino
NEPHROLOGY (2010)
B Cell Receptor-Mediated Sustained c-Rel Activation Facilitates Late Transitional B Cell Survival through Control of B Cell Activating Factor Receptor and NF-κB2
Iris Castro et al.
JOURNAL OF IMMUNOLOGY (2009)
BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells
Gamal Badr et al.
BLOOD (2008)
Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum-Induced Apoptosis in Endothelial Progenitor Cells
Shoukang Zhu et al.
CIRCULATION (2008)
TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties
Fabienne Mackay et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
CD19+CD5+ B Cells in Primary IgA Nephropathy
He Yuling et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model
Chee-Yin Wong et al.
PATHOLOGY (2008)
NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells
Yoshiteru Sasaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Regulated expression of BAFF-binding receptors during human B cell differentiation
Jaime R. Darce et al.
JOURNAL OF IMMUNOLOGY (2007)
In vitro and in vivo activation induces BAFF and APRIL expression in B cells
Van Trung Chu et al.
JOURNAL OF IMMUNOLOGY (2007)
BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism
Alina Patke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
BAFF, APRIL and their receptors: Structure, function and signaling
Claudia Bossen et al.
SEMINARS IN IMMUNOLOGY (2006)
Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells
Carrie A. Fletcher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Alternative and classical NF-κB signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease
Thomas Enzler et al.
IMMUNITY (2006)
BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT
Douglas D. McCarthy et al.
CELLULAR IMMUNOLOGY (2006)
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
CE Collins et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Lack of Il12rb2 signaling predisposes to,spontaneous autoimmunity and malignancy
I Airoldi et al.
BLOOD (2005)
B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells
M Yang et al.
JOURNAL OF IMMUNOLOGY (2005)
An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-κB signaling pathway
MD Morrison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology
Y Sasaki et al.
JOURNAL OF IMMUNOLOGY (2004)
BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders
SL Kalled et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2003)
Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators
BL Hsu et al.
JOURNAL OF IMMUNOLOGY (2002)
BAFFIed B cells survive and thrive: roles of BAFF in B-cell development
AG Rolink et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency
MH Yan et al.
CURRENT BIOLOGY (2001)
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
B Schiemann et al.
SCIENCE (2001)
TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase
A Hatzoglou et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
